
Organic Process Research and Development p. 331 - 342 (2012)
Update date:2022-08-11
Topics:
Kaemmerer, Henning
Horvath, Zoltan
Lee, Ju Weon
Kaspereit, Malte
Arnell, Robert
Hedberg, Martin
Herschend, Bjoern
Jones, Matthew J.
Larson, Kerstin
Lorenz, Heike
Seidel-Morgensten, Andreas
A racemic mixture of bicalutamide, a drug substance used in the treatment of prostate cancer, was separated by simulated moving bed chromatography, with the objective of maximizing throughput at reduced outlet purity. The enriched extract stream was purified further by a crystallization process exploiting a shift in the eutectic composition. The optimal purity in between both process steps was identified. The separation scheme developed was validated on a scale of 600 g, and the results were compared to those of state-of-the art and discussed. The investigated scheme revealed a wide range of promising coupling conditions while showing superior productivities and enhanced process robustness.
View More
Contact:86-21-50966856
Address:Building 5,300 Chuanzhan Road,Pudong New District,Shanghai
Chiral Quest (Suzhou) Company Ltd
website:http://www.chiralquest.com
Contact:+86-0512-62956066
Address:B1/9, 218 Xinghu Street, Suzhou Industrial Park
Jiangsu Zenji Pharmaceuticals LTD
Contact:+86-025-83172562; +1-224-888-1133(USA)
Address:No.5 Xinmofan Road
WENZHOU M&C FOREIGN TRADE CO.,LTD.
Contact:+86-577-88862917
Address:No.8 Liming West Road,Wenzhou,zhejiang,China
Hangzhou GreenCo Science & Technology Co., Ltd.
Contact:86-571-88257303
Address:1713 Room,Jingui Building,Gudun Road,Xihu District,Hangzhou,China
Doi:10.1002/anie.200500669
(2006)Doi:10.3390/molecules201219881
(2015)Doi:10.1246/cl.1992.795
(1992)Doi:10.1021/acs.orglett.8b01857
(2018)Doi:10.1055/s-1980-29276
(1980)Doi:10.1002/bio.3728
(2020)